BioSpace News Archive

9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, announced today the Company has appointed Michael T. Constantino to its board of directors.

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics backed by The Carlyle Group, announced Joseph M. Busky has joined the Company as Chief Financial Officer, effective July 7, 2020.

BWX Technologies, Inc. (NYSE: BWXT) today announced that Martyn Coombs has been appointed president, BWXT ITG Canada, Inc. (BWXT ITG Canada), effective July 20, 2020.

Cellectis - André Choulika, Ph.D., Cellectis’ Chairman and CEO, announces that he will focus all his energy on Cellectis’ development activities, and thus, announces his retirement from Calyxt’s Board of Directors, effective immediately.

Julius Group, a leading innovative manufacturer that combines the latest technologies with heritage craftsmanship to produce gloves and fashion accessories, and Noble Biomaterials, the global leader in antimicrobial and conductivity solutions for soft-surface applications, today announced the launch of a strategic partnership to produce reusable antiviral/antibacterial gloves and masks for consumer use.

HYGIENICA, the San Diego-based maker of industry-leading disinfecting technology, has closed its Seed Round of financing.

Santen Pharmaceutical Co., Ltd. (hereinafter, Santen) today announced that the United States Food and Drug Administration (FDA) has accepted the Premarket Approval (PMA) application for DE-128 (MicroShunt) for review.

Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced that the MELANI-01 trial has been placed on clinical hold by the U.S. Food and Drug Administration (FDA).

Community-acquired pneumonia (CAP) has been a leading cause of mortality among people with infectious diseases and affects people of all age groups.

The demand within the global hospital-acquired pneumonia prevention has been rising on account of the growing focus given on maintaining high standards of hygiene across hospitals.